This message was sent to ##Email##
|
| June 12, 2019 |
| |  | | |
|
|
|
| |
CBS News
Adding a newer drug to standard hormone therapy lengthens the lives of younger women with advanced breast cancer, a new trial has found.
The drug, called Kisqali (ribociclib), is already approved for treating such patients — based on earlier results showing it can delay the progression of their cancer.
This is the first evidence it can also extend their lives, said senior researcher Dr. Debu Tripathy, chair of the breast medical oncology department at M.D. Anderson Cancer Center in Houston.
READ MORE
| Congratulations to our 2019 Cytotechnology Graduates!
|
    |
ASCT
ASCT wishes you the best in your new profession. Remember to check out the ASCT Career Center, a free service that provides access to cytotechnology positions and employers. In addition to posting their resumes, job seekers can browse and view available jobs based on their criteria and save those jobs for later review if they choose. Job seekers can also create a search agent to provide email notifications of jobs that match their criteria. You can access the Career Center from the tab at the top bar of all Viewpoints.
Employers can post jobs online, search for qualified candidates based on specific job criteria, and create an online resume agent to email qualified candidates daily. They also benefit from online reporting that provides job activity statistics.
As a registered employer or job seeker you also have access to the National Healthcare Career Network (NHCN), a network of over 60 top healthcare associations and professional organizations. ASCT’s alliance with NHCN increases your reach to over 7,000 resumes and over 1,500 job postings – giving you more control over your career advancement and a one-stop-shop to find targeted and quality candidates.
ASCT also offers resume and interviewing tips in the Student Forum section of the ASCT website. Good luck!
 |
|
EcoVue® was designed with patient safety in mind, our non-refillable and single use products will forever CHANGE YOUR VUE of ultrasound gel.
www.EcoVue.com
|
|
| Date |
Event |
Location |
More information |
June 2019 |
The Engagement of Cytotechnologists in Genomic Selections Leads to
Improved Outcomes
|
your PC |
Melissa Randolph, BS, SCT(ASCP)
Details
|
July, 17 2019 |
TBA
|
your PC |
Eva Wojcik, MD
Department of Pathology
Loyola University Medical Center - Chicago
Details
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
Medical News Today
Researchers may have found a way to stop cancer cells from defending themselves against chemotherapy. In a new mouse study, blocking a DNA repair pathway prevented cancer cells from surviving or becoming resistant to treatment.
READ MORE
Tech Explorist
In a new study, scientists at the Noida-based ICMR-National Institute of Cancer Prevention and Research have figured out the reason why some women are prone to this cancer while others are not. According to scientists, finding this out is essential to develop early diagnostic tests in the future.
READ MORE
Precision Vaccinations
A new study of the Human papillomavirus (HPV) vaccine reported very positive results.
This study published recently, in Science Direct, used the changes in vaccine-type HPV (VT) prevalence to evaluate the vaccine’s impact on women, including herd-immunity effects.
READ MORE
PR Newswire
TMR predicts that the global liquid biopsy market, which was estimated to be worth U.S.$3,883.2 million, is projected to reach U.S.$9071.7 million by 2026. The global liquid biopsy market, thus, is anticipated to rise at 10.1% CAGR over the forecast period 2018 to 2026.
READ MORE
Medical Xpress
Surgery at high-volume centers is associated with decreased local recurrence risk and improved survival for women with early-stage cervical cancer, according to a study published in the June issue of Obstetrics & Gynecology.
READ MORE
Oncology Nursing News
Genetic and genomic testing are shaping the way that cancer is treated, improving outcomes across all tumor types. As more testing is done, it is important that both patients and providers understand the difference and work as a team to keep up with the ever-evolving field of cancer care, according to Marcia S. Brose, M.D., Ph.D., associate professor at the University of Pennsylvania School of Medicine.
READ MORE
WebMD
Each year, thousands of cancer patients seek access to drugs that have shown promise, but haven't be approved. Now they may have a better shot at getting them under a new initiative from the U.S. Food and Drug Administration, the Associated Press reported.
A case in point is that of Sally Atwater whose doctor spent two months calling and filling out forms to get an experimental drug to treat her lung cancer that had spread to her brain and spine.
READ MORE
HealthDay News via U.S. News & World Report
Colon cancer rates among those under 50 in the U.S. are rising, and they're rising the most rapidly in western states, a new study finds.
READ MORE
Cancer Network
Treatment with bone-protecting agents (BPAs) zoledronic acid or denosumab entirely eliminated the risk of fracture as seen in a study of men with metastatic castration-resistant prostate cancer (CRPC) treated with enzalutamide alone or in combination with radium-223 (Ra223).
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
